Literature DB >> 16903906

The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells.

Ethan M Shevach1, Richard A DiPaolo, John Andersson, Dong-Mei Zhao, Geoffrey L Stephens, Angela M Thornton.   

Abstract

Numerous studies over the past 10 years have demonstrated the importance of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells (nTregs) in immune regulation. We analyzed the mechanism of action of nTregs in a well-characterized model of autoimmune gastritis and demonstrated that nTregs act at an early stage of disease progression to inhibit the differentiation of naïve T cells to pathogenic T-helper 1 effectors. The effects of nTregs in this model are not antigen-specific but are mediated by activation of the nTregs by ubiquitous self-peptide major histocompatibility complex class II complexes together with cytokines released by activated effector cells. Studies in vitro confirmed that some nTregs exist in an activated state in vivo and can be activated to exert non-specific suppressor effector function by stimulation with interleukin-2 in the absence of engagement of their T-cell receptor. Natural Tregs can differentiate in vitro to exhibit potent granzyme B-dependent, partially perforin-independent cytotoxic cells that are capable of specifically killing antigen-presenting B cells. Natural Treg-mediated killing of antigen-presenting cells may represent one pathway by which they can induce long-lasting suppression of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903906     DOI: 10.1111/j.0105-2896.2006.00415.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  168 in total

Review 1.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

2.  A robust model to describe the differentiation of T-helper cells.

Authors:  Luis Mendoza; Fátima Pardo
Journal:  Theory Biosci       Date:  2010-10-05       Impact factor: 1.919

Review 3.  Regulatory T cells: roles of T cell receptor for their development and function.

Authors:  Naganari Ohkura; Shimon Sakaguchi
Journal:  Semin Immunopathol       Date:  2010-02-24       Impact factor: 9.623

4.  Protein kinase C-theta mediates negative feedback on regulatory T cell function.

Authors:  Alexandra Zanin-Zhorov; Yi Ding; Sudha Kumari; Mukundan Attur; Keli L Hippen; Maryanne Brown; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

5.  Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function.

Authors:  Dat Q Tran; Deborah D Glass; Gulbu Uzel; Dirk A Darnell; Christine Spalding; Steven M Holland; Ethan M Shevach
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

6.  Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection.

Authors:  Julie Ribot; Geneviève Enault; Sylvie Pilipenko; Anne Huchenq; Maryline Calise; Denis Hudrisier; Paola Romagnoli; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  Role of endogenous and induced regulatory T cells during infections.

Authors:  Elizabeth Wohlfert; Yasmine Belkaid
Journal:  J Clin Immunol       Date:  2008-09-23       Impact factor: 8.317

9.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.